Pacific Biosciences of California (PACB) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
19 Jan, 2026Overview of PacBio HiFi sequencing and automation
HiFi sequencing offers long, accurate reads, enabling comprehensive genome analysis, phasing, and direct methylation detection.
Library prep for HiFi sequencing is a streamlined five-step process, with automation now possible for high-quality results.
Automated workflows can match manual performance, producing high-yield, high-quality libraries with minimal hands-on time.
Core lab challenges and automation needs
Genomics core labs face scaling challenges due to high sample diversity, staff turnover, and complex protocols.
Existing automation platforms often lack flexibility, have high failure rates, or are not compatible with diverse sample types and batch sizes.
Automation is needed to free up staff, ensure reproducibility, and support a growing array of sequencing technologies.
Evaluation and implementation of Callisto platform
Callisto supports flexible batch sizes (1–24 samples), is technology- and application-agnostic, and requires minimal user training.
Installation and validation were rapid, with successful 24-sample runs completed in under a day.
Callisto uses half the reagent volume and one-third the pipette tips compared to manual prep, reducing costs and consumable use.
Latest events from Pacific Biosciences of California
- SPARQ-Nx chemistry and global clinical expansion set the stage for accelerated growth in 2026.PACB
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Record consumable growth, margin gains, and SparkNex launch set stage for 2026 expansion.PACB
Q4 202513 Feb 2026 - Clinical expansion, innovation, and margin gains drive growth amid global market shifts.PACB
TD Cowen 45th Annual Healthcare Conference3 Feb 2026 - All proposals passed, with leadership addressing share price declines and affirming strategic focus.PACB
AGM 20243 Feb 2026 - Q2 revenue fell on weak instrument sales, but consumables rose 24% and cost controls took effect.PACB
Q2 20242 Feb 2026 - Gross margin gains, R&D progress, and strong sales funnel signal a positive outlook.PACB
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue rose sequentially as new products and debt restructuring set up future growth.PACB
Q3 202415 Jan 2026 - New chemistry and benchtop sequencer expand access and lower costs, driving future growth.PACB
UBS Global Healthcare Conference 202414 Jan 2026 - New chemistry and benchtop platforms drive adoption and position for growth in 2025.PACB
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026